                               SEQUENCE LISTING

<110> BETH ISRAEL-DEACONESS MEDICAL CENTER, INC.
 
<120> ARSENIC COMPOUNDS AND RETINOIC ACID COMPOUNDS FOR TREATMENT OF
      IDH-ASSOCIATED DISORDERS

<130> 075500-0109

<140> PCT/US2019/064327
<141> 2019-12-03

<150> 62/774,712
<151> 2018-12-03

<160> 12    

<170> PatentIn version 3.5

<210> 1
<211> 24
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 1
tcctccagtt gatagagaaa aaca                                              24


<210> 2
<211> 19
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 2
gcgagcatgt agccagttg                                                    19


<210> 3
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 3
ggggataaca gcagtgagca                                                   20


<210> 4
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 4
ccacgctttt tgtgacgctt                                                   20


<210> 5
<211> 22
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 5
ggtggagatg atctctcaac tt                                                22


<210> 6
<211> 22
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 6
ccagcaagct tgcaacctta ac                                                22


<210> 7
<211> 24
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 7
gaagaacaat ccagactagc agca                                              24


<210> 8
<211> 25
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 8
ccttataggg aacttcacat cacag                                             25


<210> 9
<211> 19
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 9
gcagagcctc aggctcgcg                                                    19


<210> 10
<211> 17
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 10
ggctgctctt gcgaggt                                                      17


<210> 11
<211> 18
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 11
gcttcctgga gggtgtcc                                                     18


<210> 12
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 12
ggactcgttt gtacccgttg                                                   20


